NUGL (NUGL) Stock Price, Quote, News & History

NUGL Inc (NUGL) Stock Price, Quote, News & History

NUGLOTCID

Trade with Public

$0.00137

-0.00023-14.38%

At close: Mar 23, 5:00 PM EST

$0.00190

0.000318.75%

Pre-Market: 8:10 AM EST

Key Statistics

Open

$0.00

Volume / Avg.

0 / 1.11M

Day Range

- - -

52 Wk Range

0.00 - 0.01

Market Cap

$1.37M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent NUGL Inc News

'Oregonians Have High Standards When It Comes To Their Weed' Says Mike Tyson, As Products Launch Throughout State

Nina Zdinjak

Mike Tyson's Cannabis Infused Pre-Rolls And Vapes Reach Jamaica Via Kaya Group Partnership

Nina Zdinjak

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-510.90K

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

508.79K

Free Cash Flow (TTM)

-510.90K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.11K

Valuation Metrics

Enterprise Value

$1.37M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$748.13K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$107.81K

Debt to Equity

0.78

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.00

Volume / Avg.

0 / 1.11M

Day Range

- - -

52 Wk Range

0.00 - 0.01

Market Cap

$1.37M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Industrials

Industry

Commercial Services & Supplies

NUGL Inc, along with Kaya Group, operates a multifaceted cannabis lifestyle company with a portfolio of brands. Kaya operates lifestyle and wellness brands from various locations, a consumption lounge, and a maintenance facility. Each retail facility...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NUGL (NUGL) stock?

You can purchase shares of NUGL (OTCID:NUGL) through any online brokerage.

View our list of the best stock brokerages

Who are NUGL (NUGL) competitors?

There are no as such competitors for NUGL.

What is the forecast, or price target, for NUGL (NUGL) stock?

There is no analysis for NUGL to provide a consensus price target.

What is the current price for NUGL (NUGL)?

The stock price for NUGL (OTCID: NUGL) is $0.00137 last updated March 24, 2026 at 2:45 PM EDT.

Does NUGL (NUGL) pay a dividend?

There are no upcoming dividends for NUGL.

When is NUGL (OTCID:NUGL) reporting earnings?

NUGL does not have any upcoming earnings scheduled.

Is NUGL (NUGL) going to split?

There is no upcoming split for NUGL.

What sector and industry does NUGL (NUGL) operate in?

NUGL is in the Industrials sector and Commercial Services & Supplies industry. They are listed on the OTCID.

Key Statistics

Open

$0.00

Volume / Avg.

0 / 1.11M

Day Range

- - -

52 Wk Range

0.00 - 0.01

Market Cap

$1.37M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent NUGL Inc News

'Oregonians Have High Standards When It Comes To Their Weed' Says Mike Tyson, As Products Launch Throughout State

Nina Zdinjak

Mike Tyson's Cannabis Infused Pre-Rolls And Vapes Reach Jamaica Via Kaya Group Partnership

Nina Zdinjak

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

Lara Goldstein